 |
 |
| Despite concerted efforts to boost sales and the development of new diode laser equipment for more comfortable dental procedures, Biolase has continued to struggle financially and its stock price has traded below $1 for much of the past year. Image: nasdaq.com. |
| © 2024 SPIE Europe |
|
